ERBB2 and breast carcinoma: Although ErbB3 is frequently overexpressed in breast cancer and co-expression of ErbB2/3 is known to be a poor prognostic indicator, the role of ErbB3 in breast cancer progression has only recently attempted to pay attention23, 24, 25, 26, 27.